Grants, awards and donations
Photo: Ulf SirbornERC Proof of Concept Grant to Emma Andersson will lead to fewer laboratory animals
Emma R. Andersson has been awarded the prestigious ERC Proof of Concept Grant to further develop her technique to create mice with specific genetic signatures. “This innovation can lead to a drastic reduction in the number of animal experiments worldwide, not just in my lab,” she says.
Photo: Liza SimonssonKI researchers dominate the Swedish Research Council's call for international postdocs
Seven out of eight awarded grants go to researchers at Karolinska Institutet in the Swedish Research Council's spring call for international postdocs in medicine and health. In total, 8 out of 44 applications were approved.
Photo: Andreas Andersson,Stefan ZimmermanERC grants to KI researchers for new treatments for breast cancer and inflammation
Kristina Gemzell Danielsson will develop contraceptives that protect against breast cancer, while Thomas Helleday aims for new points of attack to counteract chronic inflammation and, by extension, cancer, autoimmunity and ageing. They receive the ERC Advanced Grant for their projects.
Photo: Martin StenmarkBjörn Gysell is donating to research into future treatments for prostate cancer
A prostate cancer research initiative in Sweden has been made possible by a donation from the entrepreneur and inventor Björn Gysell. The investment will enable Karolinska Institutet’s leading research environment in prostate cancer to develop the next generation diagnostics and therapies using AI, genomics and precision medicine.
The Conversation
Photo: Getty ImagesA single dose of psilocybin eased depression symptoms for months
A single dose of the psychedelic substance psilocybin, found in so-called magic mushrooms, can provide rapid relief from recurrent depression, with the effects lasting for over three months, according to a new study. However, the researchers also caution that the results may have been influenced by the placebo effect. Read the article in The Conversation.
Photo: Getty ImagesNew study downplays the risk of atrial fibrillation in fit people
New research suggests that the risk of atrial fibrillation in highly fit people is lower than previously thought. The benefits of high fitness levels, including lower rates of cardiovascular disease, clearly outweigh any potential downsides. Read the article in The Conversation.
Photo: Getty ImagesWhy has PCOS been given a new name?
After decades of research, PCOS is now being renamed PMOS. The new name reflects a growing understanding that the condition is a complex hormonal and metabolic disorder affecting far more than fertility.
Photo: Getty ImagesMore articles by KI researchers published in The Conversation
From cold-resistant genes to face masks, Karolinska Institutet researchers contribute to the global public discourse on a range of topics through our collaboration with the international news site The Conversation.
The magazine Medicinsk Vetenskap on AI in healthcare
Photo: Peter GehrmanMore and more people are turning to Dr AI for advice
Dr AI has become a colleague of Dr Google. Researchers see both benefits and risks in this development. First published in the magazine Medicinsk Vetenskap no 2 2026.
Photo: Christian GustavssonHow AI can accelerate drug development
Andreas Luttens has trained an algorithm that can explore the so-called chemical space – all conceivable combinations of atoms and bonds. First published in the magazine Medicinsk Vetenskap no 2 2026.
Selected top publications
Staff practices determine the use of coercion against young people
Astrid Moell et al, Lancet Psychiatry, June 2026
Biological differences linked to severe COVID-19
Soham Gupta et al, Genome Medicine, May 2026
From PCOS to PMOS: why the name of a disease matters
Elisabet Stener-Victorin et al, Nature Medicine, May 2026
Chronic bowel disease involves multiple types of inflammation happening at once
Eduardo J. Villablanca et al, Immunity, May 2026
New insights into protein breakdown in cells pave the way for new medicines
Helin Norberg et at, Trends in Pharmacological Sciences, April 2026
More high-impact publications